[VRDN] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
08-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -12.72%
YoY- -149.50%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 880 695 2,514 372 476 944 2,182 -45.32%
PBT -10,118 -11,230 -8,896 -11,629 -10,317 -9,011 -8,714 10.44%
Tax 50 133 204 339 289 362 361 -73.13%
NP -10,118 -11,230 -8,896 -11,629 -10,317 -9,011 -8,714 10.44%
Tax Rate - - - - - - - -
Total Cost 10,998 11,925 11,410 12,001 10,793 9,955 10,896 0.62%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin -1,149.77 -1,615.83 -353.86 -3,126.08 -2,167.44 -954.56 -399.36 101.98%
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -4.69 -5.42 -4.31 -5.65 -5.02 -4.40 -4.31 5.77%
EPS Diluted -4.69 -5.42 -4.31 -5.65 -5.02 -4.40 -4.31 5.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.